Indication
Nonsquamous non-small cell lung cancer
Nonsquamous non-small cell lung cancer is a broad clinicopathologic grouping of epithelial lung malignancies that excludes squamous cell carcinoma, primarily comprising adenocarcinoma, large cell carcinoma, and other rare non-small cell subtypes. Read more about Nonsquamous non-small cell lung cancer
52 drugs 39 manufacturers
Drugs that treat it
Common Nonsquamous non-small cell lung cancer therapies.
CARBOPLATIN
CARBOPLATIN
CARBOPLATIN
CARBOPLATIN
CARBOPLATIN
CARBOPLATIN
CARBOPLATIN
MVASI (bevacizumab-awwb)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNonsquamous non-small cell lung cancer is a broad clinicopathologic grouping of epithelial lung malignancies that excludes squamous cell carcinoma, primarily comprising adenocarcinoma, large cell carcinoma, and other rare non-small cell subtypes.
Arising within the respiratory system—predominantly from the peripheral lung parenchyma and alveolar epithelium—it is the most prevalent form of non-small cell lung cancer.
Pathophysiologically, it is characterized by uncontrolled cellular proliferation and invasiveness driven by genomic alterations, demonstrating a significantly higher frequency of actionable oncogenic driver alterations—such as mutations in EGFR or KRAS and fusions in ALK, ROS1, or RET—than squamous histology.
Patients commonly present with pulmonary symptoms such as persistent cough, dyspnea, and hemoptysis, or with manifestations of locoregional invasion and distant metastasis.
- targetedonc.com
Nonsquamous non-small cell lung cancer is a broad clinicopathologic grouping of epithelial lung malignancies that excludes squamous cell carcinoma, primarily comprising adenocarcinoma, large cell carcinoma, and other rare non-small cell subtypes Arising within the respiratory system—predominantly from the peripheral lung parenchyma and alveolar epithelium—it is the most prevalent form of non-small cell lung cancer Pathophysiologically, it is characterized by uncontrolled cellular proliferation a...
- cancer.gov
Nonsquamous non-small cell lung cancer is a broad clinicopathologic grouping of epithelial lung malignancies that excludes squamous cell carcinoma, primarily comprising adenocarcinoma, large cell carcinoma, and other rare non-small cell subtypes
- nih.gov
Nonsquamous non-small cell lung cancer is a broad clinicopathologic grouping of epithelial lung malignancies that excludes squamous cell carcinoma, primarily comprising adenocarcinoma, large cell carcinoma, and other rare non-small cell subtypes Arising within the respiratory system—predominantly from the peripheral lung parenchyma and alveolar epithelium—it is the most prevalent form of non-small cell lung cancer
- koreamed.org
Pathophysiologically, it is characterized by uncontrolled cellular proliferation and invasiveness driven by genomic alterations, demonstrating a significantly higher frequency of actionable oncogenic driver alterations—such as mutations in EGFR or KRAS and fusions in ALK, ROS1, or RET—than squamous histology
- nih.gov
Patients commonly present with pulmonary symptoms such as persistent cough, dyspnea, and hemoptysis, or with manifestations of locoregional invasion and distant metastasis
Personalize your experience
Follow Nonsquamous non-small cell lung cancer and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.